ClinActis, a specialist Asia Pacific Clinical Research Organisation, today announced the appointment of Lindsay Bickerton as Director of Business Development, to take the company through the next phase of growth.

Lindsay brings to ClinActis four years experience working within the clinical research industry on a global level. Further to this, she has worked in a number of sales and marketing positions in a variety of industries, including medical. This new role will involve growing new business, both by working closely with existing customers and through the development of new customer relationships, in addition to raising the profile of ClinActis across both Europe and the US.  

​

Lindsay Bickerton commented: ‘I am excited to join ClinActis at such an important time of the company’s development and establishing them as the partner of choice in this region. Asia Pacific offers huge clinical research potential and is still a region which is relatively untapped. As a regional CRO, ClinActis understands the variety of languages, cultures and regulations involved working in this region. This local knowledge, along with their extensive relations with the regulatory authorities, is invaluable and ensures ClinActis’ Clinical Operations team are able to guide Sponsors smoothly through the clinical development stages. Sponsors need a reliable and trusted partner for this region with short communication lines and ClinActis is offering exactly that.’

​

Christophe Tournerie, CEO of ClinActis, added: ‘We are extremely pleased to welcome Lindsay to the ClinActis team. Being based in the UK, she will be able to offer a seamless link between our offices throughout Asia Pacific and our clients based in Europe and the US. Lindsay will bring her solid experience of the CRO business and pharmaceutical industry, as well as her understanding of the critical success factors behind international clinical research.’

​

About ClinActis

ClinActis Pte Ltd is a Clinical Research Organization specialising in Asia Pacific, providing pharmaceutical, medical device, medical nutrition and biotech companies with state of the art clinical research services with an approach fully customized to the specificities of Asia Pacific.

​

With Headquarters based in Singapore ClinActis can provide coverage in countries including Malaysia, Thailand, the Philippines, Vietnam, Indonesia, Taiwan, India, China, Hong Kong, Korea and Australia. Although the region offers research potential in virtually all therapeutic areas, key areas of continued growth for ClinActis’ lies in Cardiovascular, CNS, Endocrinology, Infectious diseases, Oncology, Orphan and Respiratory diseases.

 

For more information visit www.clinactis.com